BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20920193)

  • 1. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.
    Pinhel IF; Macneill FA; Hills MJ; Salter J; Detre S; A'hern R; Nerurkar A; Osin P; Smith IE; Dowsett M
    Breast Cancer Res; 2010; 12(5):R76. PubMed ID: 20920193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.
    Leal MF; Haynes BP; MacNeill FA; Dodson A; Dowsett M
    Breast Cancer Res Treat; 2019 Jun; 175(2):317-326. PubMed ID: 30796652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
    Neumeister VM; Anagnostou V; Siddiqui S; England AM; Zarrella ER; Vassilakopoulou M; Parisi F; Kluger Y; Hicks DG; Rimm DL
    J Natl Cancer Inst; 2012 Dec; 104(23):1815-24. PubMed ID: 23090068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases.
    Schmitz KJ; Otterbach F; Callies R; Levkau B; Hölscher M; Hoffmann O; Grabellus F; Kimmig R; Schmid KW; Baba HA
    Mod Pathol; 2004 Jan; 17(1):15-21. PubMed ID: 14631376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
    Bliss JM; Tovey H; Evans A; Holcombe C; Horgan K; Mallon E; Vidya R; Skene A; Dodson A; Hills M; Detre S; Zabaglo L; Banerji J; Kilburn L; Morden JP; Robertson JFR; Smith I; Dowsett M;
    Breast Cancer Res; 2023 Apr; 25(1):39. PubMed ID: 37046348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.
    Arima N; Nishimura R; Osako T; Nishiyama Y; Fujisue M; Okumura Y; Nakano M; Tashima R; Toyozumi Y
    J Clin Pathol; 2016 Mar; 69(3):255-9. PubMed ID: 26420767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
    Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
    BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time.
    Vassilakopoulou M; Parisi F; Siddiqui S; England AM; Zarella ER; Anagnostou V; Kluger Y; Hicks DG; Rimm DL; Neumeister VM
    Lab Invest; 2015 Mar; 95(3):334-41. PubMed ID: 25418580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
    López-Knowles E; Gao Q; Cheang MC; Morden J; Parker J; Martin LA; Pinhel I; McNeill F; Hills M; Detre S; Afentakis M; Zabaglo L; Dodson A; Skene A; Holcombe C; Robertson J; Smith I; Bliss JM; Dowsett M;
    Breast Cancer Res; 2016 Apr; 18(1):39. PubMed ID: 27036195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in formalin-fixed breast carcinoma cell block preparations: correlation of results to corresponding tissue block (needle core and excision) samples.
    Kinsella MD; Birdsong GG; Siddiqui MT; Cohen C; Hanley KZ
    Diagn Cytopathol; 2013 Mar; 41(3):192-8. PubMed ID: 22611048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
    Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies: a double-centre study.
    Kalkman S; Bulte JP; Halilovic A; Bult P; van Diest PJ
    Histopathology; 2015 Feb; 66(3):380-7. PubMed ID: 25234295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.
    Gündisch S; Annaratone L; Beese C; Drecol E; Marchiò C; Quaglino E; Sapino A; Becker KF; Bussolati G
    Lab Invest; 2015 May; 95(5):561-71. PubMed ID: 25730369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of phosphorylated proteins in tissue specimens requires high-quality samples collected under stringent conditions.
    Wolf C; Jarutat T; Vega Harring S; Haupt K; Babitzki G; Bader S; David K; Juhl H; Arbogast S
    Histopathology; 2014 Feb; 64(3):431-44. PubMed ID: 24266863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
    Yamashita-Kashima Y; Shu S; Yorozu K; Hashizume K; Moriya Y; Fujimoto-Ouchi K; Harada N
    Gastric Cancer; 2014 Oct; 17(4):638-47. PubMed ID: 24414131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.
    Berg D; Langer R; Tran K; Walch A; Schuster T; Bronger H; Becker KF
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):300-5. PubMed ID: 21293257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.
    Robertson S; Rönnlund C; de Boniface J; Hartman J
    Breast Cancer Res Treat; 2019 Apr; 174(3):795-805. PubMed ID: 30659433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative validation of the SP6 antibody to Ki67 in breast cancer.
    Zabaglo L; Salter J; Anderson H; Quinn E; Hills M; Detre S; A'Hern R; Dowsett M
    J Clin Pathol; 2010 Sep; 63(9):800-4. PubMed ID: 20671052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.